Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 503

1.

Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.

Davis HR, Veltri EP.

J Atheroscler Thromb. 2007 Jun;14(3):99-108. Review.

PMID:
17587760
[PubMed - indexed for MEDLINE]
Free Article
2.

Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.

Yamagishi S, Nakamura K, Matsui T, Sato T, Takeuchi M.

Med Hypotheses. 2006;66(4):844-6. Epub 2005 Sep 26.

PMID:
16188393
[PubMed - indexed for MEDLINE]
3.

Ezetimibe: a selective cholesterol absorption inhibitor.

Nutescu EA, Shapiro NL.

Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.

PMID:
14620392
[PubMed - indexed for MEDLINE]
4.

Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).

Davis HR Jr, Basso F, Hoos LM, Tetzloff G, Lally SM, Altmann SW.

Atheroscler Suppl. 2008 Sep;9(2):77-81. doi: 10.1016/j.atherosclerosissup.2008.05.008. Epub 2008 Jun 27. Review.

PMID:
18585981
[PubMed - indexed for MEDLINE]
5.

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.

Simon JS, Karnoub MC, Devlin DJ, Arreaza MG, Qiu P, Monks SA, Severino ME, Deutsch P, Palmisano J, Sachs AB, Bayne ML, Plump AS, Schadt EE.

Genomics. 2005 Dec;86(6):648-56. Epub 2005 Nov 16.

PMID:
16297596
[PubMed - indexed for MEDLINE]
Free Article
6.

Ezetimibe: cholesterol lowering and beyond.

Bays HE, Neff D, Tomassini JE, Tershakovec AM.

Expert Rev Cardiovasc Ther. 2008 Apr;6(4):447-70. doi: 10.1586/14779072.6.4.447. Review.

PMID:
18402536
[PubMed - indexed for MEDLINE]
7.

Ezetimibe: rationale and role in the management of hypercholesterolemia.

Yatskar L, Fisher EA, Schwartzbard A.

Clin Cardiol. 2006 Feb;29(2):52-5. Review.

PMID:
16506638
[PubMed - indexed for MEDLINE]
8.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
[PubMed - indexed for MEDLINE]
9.

Ezetimibe for hypercholesterolemia.

Morris S, Tiller R.

Am Fam Physician. 2003 Oct 15;68(8):1595-6.

PMID:
14596448
[PubMed - indexed for MEDLINE]
Free Article
10.

Ezetimibe in hypercholesterolaemia.

Farnier M.

Int J Clin Pract. 2002 Oct;56(8):611-4.

PMID:
12425372
[PubMed - indexed for MEDLINE]
11.

Intestinal sterol transporters and cholesterol absorption inhibition.

Davis HR Jr, Tershakovec AM, Tomassini JE, Musliner T.

Curr Opin Lipidol. 2011 Dec;22(6):467-78. doi: 10.1097/MOL.0b013e32834c7c28. Review.

PMID:
22101558
[PubMed - indexed for MEDLINE]
12.

Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor.

Jeu L, Cheng JW.

Clin Ther. 2003 Sep;25(9):2352-87. Review.

PMID:
14604738
[PubMed - indexed for MEDLINE]
13.

In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.

Hawes BE, O'neill KA, Yao X, Crona JH, Davis HR Jr, Graziano MP, Altmann SW.

Mol Pharmacol. 2007 Jan;71(1):19-29. Epub 2006 Sep 27.

PMID:
17005902
[PubMed - indexed for MEDLINE]
Free Article
14.

[Ezetimibe: from pharmacology to clinical trials].

Tellier P.

Ann Endocrinol (Paris). 2003 Dec;64(6):442-7. Review. French.

PMID:
15067249
[PubMed - indexed for MEDLINE]
15.

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel.

Mikhailidis DP, Wierzbicki AS, Daskalopoulou SS, Al-Saady N, Griffiths H, Hamilton G, Monkman D, Patel V, Pittard J, Schachter M.

Curr Med Res Opin. 2005 Jun;21(6):959-69.

PMID:
15969896
[PubMed - indexed for MEDLINE]
16.

Niemann-pick C1-like 1 mediates alpha-tocopherol transport.

Narushima K, Takada T, Yamanashi Y, Suzuki H.

Mol Pharmacol. 2008 Jul;74(1):42-9. doi: 10.1124/mol.107.043034. Epub 2008 Apr 10.

PMID:
18403720
[PubMed - indexed for MEDLINE]
Free Article
17.

The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.

Ge L, Wang J, Qi W, Miao HH, Cao J, Qu YX, Li BL, Song BL.

Cell Metab. 2008 Jun;7(6):508-19. doi: 10.1016/j.cmet.2008.04.001.

PMID:
18522832
[PubMed - indexed for MEDLINE]
Free Article
18.

[Cholesterol homeostasis and enterohepatic connection: new insights in cholesterol absorption].

Klop B, Elte JW, Cabezas MC.

Ned Tijdschr Geneeskd. 2011;155:A2503. Review. Dutch.

PMID:
21262010
[PubMed - indexed for MEDLINE]
19.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
[PubMed - indexed for MEDLINE]
20.

Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways.

Turley SD.

Clin Cardiol. 2004 Jun;27(6 Suppl 3):III16-21. Review.

PMID:
15239487
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk